Projects per year
Personal profile
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Fingerprint
- 1 Similar Profiles
Network
-
CoVPN 3004 Protocol Funding
Fred Hutchinson Cancer Research Center
9/1/20 → 11/30/22
Project: Research project
-
National Ebola Training and Education Center (NETEC) Supplement
6/30/20 → 6/29/22
Project: Research project
-
CoVPN 3006 Site Preparedness
Fred Hutchinson Cancer Research Center
4/15/21 → 11/30/21
Project: Research project
-
COVID-19 Prevention Network (CoVPN) Site Preparation
Kline, S. E., Bold, T. D. & Schacker, T. W.
Fred Hutchinson Cancer Research Center
9/1/20 → 11/30/21
Project: Research project
-
Identification of Natural SARS-CoV-2 Infection in Seroprevalence Studies Among Vaccinated Populations
Demmer, R. T., Baumgartner, B., Wiggen, T. D., Ulrich, A. K., Strickland, A. J., Naumchik, B. M., Bohn, B., Walsh, S., Smith, S., Kline, S., Stovitz, S. D., Yendell, S., Beebe, T. J. & Hedberg, C., Apr 2022, In: Mayo Clinic Proceedings. 97, 4, p. 754-760 7 p.Research output: Contribution to journal › Article › peer-review
Open Access1 Scopus citations -
SARS-CoV-2 seroprevalence among healthcare workers
Wiggen, T. D., Bohn, B., Ulrich, A. K., Stovitz, S. D., Strickland, A., Naumchik, B. M., Walsh, S., Smith, S., Baumgartner, B., Kline, S., Yendell, S., Hedberg, C., Beebe, T. J. & Demmer, R. T., Apr 2022, In: PloS one. 17, 4 April, e0266410.Research output: Contribution to journal › Article › peer-review
Open Access -
Baricitinib plus remdesivir for hospitalized adults with Covid-19
ACTT-2 Study Group Members, Mar 4 2021, In: New England Journal of Medicine. 384, 9, p. 795-807 13 p.Research output: Contribution to journal › Article › peer-review
Open Access549 Scopus citations -
Efficacy of interferon beta-1a plus remdesivir compared with remdesivir alone in hospitalised adults with COVID-19: a double-bind, randomised, placebo-controlled, phase 3 trial
ACTT-3 study group members, Dec 2021, In: The Lancet Respiratory Medicine. 9, 12, p. 1365-1376 12 p.Research output: Contribution to journal › Article › peer-review
Open Access10 Scopus citations -
Immune Profiling to Determine Early Disease Trajectories Associated With Coronavirus Disease 2019 Mortality Rate: A Substudy from the ACTT-1 Trial
Thiede, J. M., Gress, A. R., Libby, S. D., Ronayne, C. E., Matchett, W. E., Noren, B., Billings, J. L., Menachery, V. D., Langlois, R. A., Kline, S. & Bold, T. D., Apr 23 2021, In: The Journal of infectious diseases. 223, 8, p. 1339-1344 6 p.Research output: Contribution to journal › Article › peer-review
Open Access
Press / Media
-
What You Need to Know About Remdesivir, the First FDA-Approved Treatment for COVID-19
10/30/20
1 item of Media coverage
Press/Media: Expert Comment or Interview
-
Remdesivir's effectiveness in fighting COVID-19
10/16/20
1 item of Media coverage
Press/Media: Expert Comment or Interview
-
This survivor may have had Covid-19 twice
10/5/20
1 item of Media coverage
Press/Media: Expert Comment or Interview
-
4 Out of 5 People With COVID-19 Will Develop Symptoms: Study
9/22/20
1 item of Media coverage
Press/Media: Expert Comment or Interview
-
How to distinguish between COVID-19 and allergy symptoms
8/19/20
1 item of Media coverage
Press/Media: Expert Comment or Interview